MDLZ
30
2
ADBE
49
3
GE
65
4
UAL
73
7
USB
50
6
NOV
57
4
TGNA
37
5
PM
50
3
CRM
64
5
PH
67
3
VFC
72
6
SO
68
2
FRT
38
2
MAT
56
5
AAL
51
9
MCK
45
3
LB
56
11
NWSA
45
2
MA
62
2
MAR
66
7
MDLZ
30
2
ADBE
49
3
GE
65
4
UAL
73
7
USB
50
6
NOV
57
4
TGNA
37
5
PM
50
3
CRM
64
5
PH
67
3
VFC
72
6
SO
68
2
FRT
38
2
MAT
56
5
AAL
51
9
MCK
45
3
LB
56
11
NWSA
45
2
MA
62
2
MAR
66
7
Financhill
Back

Bioxytran 10K Form

Sell
50

BIXT
Bioxytran

Last Price:
0.1100
Seasonality Move:
2642.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIXT News And Ratings

See the #1 stock for the next 7 days that we like better than BIXT

BIXT Financial Statistics

Sales & Book Value

Annual Sales: $191.08K
Cash Flow: $-55.5K
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

EPS (TTM): -0.02870
Net Income (TTM): $-3.51M
Gross Margin: $87.1K
Return on Equity: 0%
Return on Assets: 0%

Bioxytran Earnings Forecast

Key Bioxytran Financial Ratios

  • The Gross Profit Margin over the past 10 years for BIXT is 45.58%.
  • The Selling, General & Administrative Expenses for BIXT have been equal to 208.13% of Gross Profit Margin.
  • The Interest Expense is -12.66% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 8 years.

Bioxytran Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIXT
Website: bioxytraninc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIXT Technical Analysis vs Fundamental Analysis

Sell
50
Bioxytran (BIXT) is a Sell

Is Bioxytran a Buy or a Sell?

  • Bioxytran stock is rated a Sell
    The current Bioxytran [BIXT] share price is $0.1120. The Score for BIXT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.